Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Clinical EEG and Neuroscience
|
October 19, 2020
Alterations of Resting EEG in Hallucinating and Nonhallucinating Schizophrenia Patients
Madhav Arora, Verner J Knott, Alain Labelle, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 3, 2017
Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study
Danielle Impey, Ashley Baddeley, Renee Nelson, et al.
Biological Psychology
|
May 29, 2014
Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness
Derek J Fisher, Dylan M Smith, Alain Labelle, et al.
Journal of Clinical Psychopharmacology
|
November 28, 2002
Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study
Alain Labelle, Dominique Bourget, Luc Jean Boulay, et al.
Frontiers in Psychiatry
|
October 23, 2020
Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia
Ashley M Francis, Verner J Knott, Alain Labelle, et al.
ISRN Psychiatry
|
June 6, 2013
Familial paraphilia: a pilot study with the construction of genograms
Alain Labelle, Dominique Bourget, John M W Bradford, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
February 2, 2021
Retrospective review of use of adjunctive psychostimulants in patients with schizophrenia
Naista Zhand, Philip Harvey, Roisin Osborne, et al.
Clinical EEG and Neuroscience
|
November 5, 2024
Speech Mismatch Negativity (MMN) in Schizophrenia with Auditory Verbal Hallucinations
Bronwen Schryver, Aster Javier, Joëlle Choueiry, et al.
Journal of Clinical Psychopharmacology
|
June 17, 2026
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial
Naista Zhand, Ridha Joober, Alain Labelle, et al.
Contemporary Clinical Trials Communications
|
August 29, 2024
Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes
Naista Zhand, David Attwood, Alain Labelle, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Clinical EEG and Neuroscience
|
October 19, 2020
Alterations of Resting EEG in Hallucinating and Nonhallucinating Schizophrenia Patients
Madhav Arora, Verner J Knott, Alain Labelle, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 3, 2017
Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study
Danielle Impey, Ashley Baddeley, Renee Nelson, et al.
Biological Psychology
|
May 29, 2014
Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness
Derek J Fisher, Dylan M Smith, Alain Labelle, et al.
Journal of Clinical Psychopharmacology
|
November 28, 2002
Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study
Alain Labelle, Dominique Bourget, Luc Jean Boulay, et al.
Frontiers in Psychiatry
|
October 23, 2020
Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia
Ashley M Francis, Verner J Knott, Alain Labelle, et al.
ISRN Psychiatry
|
June 6, 2013
Familial paraphilia: a pilot study with the construction of genograms
Alain Labelle, Dominique Bourget, John M W Bradford, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
February 2, 2021
Retrospective review of use of adjunctive psychostimulants in patients with schizophrenia
Naista Zhand, Philip Harvey, Roisin Osborne, et al.
Clinical EEG and Neuroscience
|
November 5, 2024
Speech Mismatch Negativity (MMN) in Schizophrenia with Auditory Verbal Hallucinations
Bronwen Schryver, Aster Javier, Joëlle Choueiry, et al.
Journal of Clinical Psychopharmacology
|
June 17, 2026
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial
Naista Zhand, Ridha Joober, Alain Labelle, et al.
Contemporary Clinical Trials Communications
|
August 29, 2024
Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes
Naista Zhand, David Attwood, Alain Labelle, et al.
Page
of 5